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Spinal cord injury (SCI) occurs most commonly as a result 
of trauma, although the proportion of cases related to non-
traumatic aetiologies is rising over time. It has been esti-
mated that the worldwide incidence of SCI lies between 
250,000 and 500,000 per year. Injury to the spinal cord is 
devastating for patients; in addition to the loss of motor and 
sensory function, patients frequently require on-going man-
agement of bladder and bowel symptoms, pain, autonomic 
dysfunction and the psychological consequences of chronic 
disability. In higher income countries, access to rehabilita-
tion and specialist medical care improves outcomes, but the 
ability to walk, or even stand again remains unachievable 
for many.
Currently activity-based therapies are the only medical 
intervention known to aid recovery, although patients with-
out any voluntary muscle control receive minimal benefit. 
As a result, and to aid motor recovery after SCI, neurotech-
nology has been an important focus of research. The aim of 
such technologies is to enable active movement to enhance 
reorganisation of neuronal pathways and subsequent func-
tional improvement. Of currently available technologies 
which have been examined in clinical trials, epidural electri-
cal stimulation (EES) of the spinal cord is considered to have 
the most potential in achieving these goals. By stimulating 
proprioceptive circuits in the posterior roots of the spinal 
cord, EES activates motor neurone pools and augments 
residual, spared descending pathways under supraspinal 
control.
The three papers reviewed in this month’s journal club 
consider the role of EES in restoring over-ground walking 
in patients with SCI. Although these studies largely provide 
proof-of-concept, they are an important and encouraging 
forward step in the more widespread use of neurotechnol-
ogy in patients with SCI. However, it is clear that further 
clinical trials will be necessary to validate results, particu-
larly to identify which patients are most likely to benefit 
and at what stage of injury the intervention will be most 
efficacious. In the near future the cost of this technology 
coupled with intensive locomotor training (LT) is likely to 
be prohibitive for the majority and particularly for patients 
in low-income countries, but offer the vision of an optimistic 
future for affected patients.
Recovery of over‑ground walking 
after chronic motor complete spinal cord 
injury
This study investigated the use of stimulation alongside LT 
for recovery of standing and walking in patients with SCI. 
Four patients with traumatic, motor complete SCI (absence 
of voluntary movement below the level of injury with or 
without preserved sensation) were selected for the study.
The initial phase of the study involved intense LT on a 
treadmill with bodyweight support and manual facilitations 
of stepping. This was performed for 2 h, 5 days per week for 
8–9 weeks. Following this, a 16-electrode epidural array was 
implanted over spinal segments L1 to S1-2 and a spinal cord 
stimulator inserted into the abdominal wall. Electromyogra-
phy (EMG) was utilised to identify the desired combination 
of electrical stimulation, which would result in enhanced 
standing and stepping movements. Three types of training 
sessions were then performed with the stimulator turned on; 
(1) stepping on a treadmill, (2) over-ground standing and (3) 
over-ground walking. Each session lasted 1 h with 1–2 train-
ing sessions per day. Over-ground walking occurred only if 
the preceding skills were attained.
Following conventional rehabilitation, patients were 
unable to stand, walk or voluntarily move their legs. Study 
treatment was then commenced 2.5–3.3 years after the initial 
injury. The initial period of intense LT did not result in any 
changes to sensory, motor or locomotive ability. Following 
therapy with epidural stimulator assistance, two patients 
with American Spinal Injury Association scale (AIS) grade 
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B (partially retained sensation) achieved the ability to walk 
over-ground with assistive devices. One of these patients (C5 
level of injury) was able to walk over-ground while using 
horizontal poles or with bilateral assistance after 85 weeks 
of therapy with a maximum continuous distance of 90.5 m 
achieved. Independent standing with a walker and sitting 
for 5 min was also accomplished. Interestingly, independ-
ent walking was only possible when the patient intended to 
walk. The other patient (T1 level of injury) was able to walk 
independently with a walker after 15 weeks. Independent 
standing whilst holding onto elastic bands for approximately 
50 min was also achieved. The other two patients, both with 
AIS grade A injuries (no movement or sensation below level 
of injury) were not able to perform over-ground walking but 
did achieve some components of independent stepping on 
the treadmill with body-weight support. They were also able 
to sit and stand independently. The main adverse outcome 
was a spontaneous hip fracture in one patient (AIS grade A) 
when stepping on the treadmill.
Comment This paper demonstrates the utility of epidural 
stimulation coupled with intensive LT therapy for patients 
with SCI. Particular benefit was observed in those patients 
with preserved sensation. Walking also only occurred when 
the intention to walk was present, which the authors specu-
late could be due to the activation of interneuronal networks 
in the lumbosacral cord. The results of this study are encour-
aging but will require replication in a larger group of patients 
to confirm efficacy and safety.
Angeli CA et al. NEJM. 2018;379(13):1244–1250.
Neuromodulation of lumbosacral spinal 
networks enables independent stepping 
after complete paraplegia
Similar to the paper by Angeli et al. this paper focuses on 
the use of EES to facilitate over-ground walking in a single 
patient with chronic SCI.
A 26-year-old male patient who experienced a traumatic 
SCI 3 years prior, with complete loss of sensorimotor func-
tion below the 6th thoracic spinal segment was included in 
the study. Following injury, the patient underwent an initial 
8 weeks of inpatient rehabilitation followed by 5 weeks of 
outpatient rehabilitation then 132 weeks without interven-
tion. Despite clinical evidence of complete loss of function, 
imaging demonstrated intact tissue within the SCI site sug-
gesting an incomplete injury.
Twenty-two weeks of LT was performed prior to implan-
tation of a 16-electrode EES array on the dorsal surface of 
the lumbosacral cord, with a pulse generator implanted in 
the abdomen. Over 43 weeks, following EES insertion, 113 
sessions of multi-modal rehabilitation (MMR) were per-
formed. MMR sessions involved task-specific training in 
the presence of EES with activities performed while supine, 
side-lying, seated, standing and stepping with trainer assis-
tance and body-weight support (BWS) as required. During 
this time, an additional 72 home-based exercise sessions 
with EES were also undertaken.
EES was optimised over the course of MMR with two 
interleaved EES programs found to enable bilateral control 
of leg function. Following initial outcomes of standing and 
intentional control of step-like leg movement using EES, 
the authors determined whether the patient could achieve 
independent stepping during 43 weeks of MMR. By week 43 
of MMR, the patient achieved independent stepping on the 
treadmill at a speed of 0.22 m/s using arms on the support 
bars for balance without trainer assistance or BWS. At this 
stage, over-ground stepping was also achieved whilst using 
a front-wheeled walker and intermittent trainer assistance to 
allow weight shifting and to maintain balance. Throughout 
the study period, EES enabled improvement in step speed, 
with the maximum number of steps and distance travelled 
in a session being 331 and 102 m, respectively. At several 
time points throughout the study, clinical evaluation did not 
demonstrate any functional change with EES turned off.
Comment The use of task-specific EES in this study 
facilitated independent standing, stepping on a treadmill, 
and stepping over-ground with front-wheeled walker and 
intermittent trainer assistance. The authors speculate that 
MMR may have enhanced and reorganised existing spinal 
neuronal networks and preserved supraspinal-spinal con-
nections associated with locomotor activities. As with the 
first paper discussed, although offering some optimism, the 
results of this study will need to be replicated in a larger 
clinical trial to confirm efficacy.
Gill ML et al. Nat Med. 2018;24(11):1677–1682.
Targeted neurotechnology restores walking 
in humans with spinal cord injury
This paper reports the use of spatiotemporal EES during 
over-ground LT training in humans with chronic SCI. The 
authors hypothesised that this technology could enable vol-
untary locomotion, leading to functional improvements with 
and without EES stimulation.
Three male patients were included in the study, each 
with a chronic unspecified cervical SCI and AIS scale C-D 
(motor incomplete). Inclusion criteria for the study speci-
fied the ability to stand with a walker or 2 crutches. Two of 
the patients were classified as being able to walk 10 metres 
with varying levels of assistance before intervention. A 
16-electrode EES array was implanted to target the lumbo-
sacral nerve roots that projected to spinal cord regions 
associated with motor neuron activation for the hip, knee 
and ankle joints necessary for locomotion. An implantable 
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pulse generator with wireless communication then enabled 
real-time control over EES parameters during over-ground 
walking. This was aided by a recording platform provid-
ing real-time processing of whole-body kinematics, ground 
reaction forces and EMG of leg muscles. A multidirectional 
gravity-assist device provided BWS.
Once optimised, patients regulated the timing of their 
movements to pre-programmed EES sequences. This ena-
bled EMG activity during stepping on a treadmill within 
5 days, followed by all patients walking voluntarily over-
ground with EES stimulation. Following this, patients were 
able to adjust their range of leg movements, stride speed and 
length and able to stop movements despite ongoing stimula-
tion. Overall, patients were able to walk on a treadmill for 
1 h with a maximum achieved distance of 1 km. Following 
an intensive, 5 month, EES-enabled rehabilitation program, 
all patients improved their walking capacities. Strikingly, 
improvements to walking were also observed when EES was 
not in use. Interestingly, when continuous EES was utilised, 
as in the first two studies reviewed here, the authors found 
this to be ineffective. In addition to over-ground walking, the 
authors also engineered a tablet-based system whereby EES 
sequences could be selected with a voice-controlled watch 
to facilitate standing, walking or cycling. To enable this, 
EES sequence algorithms were triggered and adjusted based 
on real-time acquisition of signals from wearable inertial 
measurement units.
Comment This study is remarkable for the restoration 
of walking in patients with SCI. As opposed to empirical, 
continuous stimulation used in the aforementioned studies, 
the use of spatiotemporal EES sequences coinciding with 
the intended movement allowed more natural control of leg 
movements. The authors hypothesise that through plasticity 
this increases the strength and number of spared descend-
ing pathways and is responsible for the recovery observed 
without EES. It is important to note that all patients had 
motor incomplete SCI and, therefore, the results may not 
extrapolate to those with more severe injury. In addition, this 
is a proof-of-concept study and, therefore, further clinical 
trials will be necessary to assess its true impact.
Wagner FB et al. Nature. 2018;563(7729):65–71.
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